Item 7.01. Regulation FD Disclosure.

The Company announced on December 31, 2021 that the Korean Intellectual Property Office issued the Company's patent titled 'Abuse and Misuse Deterrent Transdermal System' which is related to the Company's lead technology AVERSA™.

See Press Release attached as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits





(d) Exhibits

The following exhibits are being filed with this Current Report on Form 8-K:





99.1        Nutriband Press Release dated December 31, 2021
104       Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       1

© Edgar Online, source Glimpses